Pioneering AI Drug Discovery | Recursion
Our data and the Recursion OS enable us to train intelligent machine learning models for AI drug discovery and development, which help us rapidly identify new targets and design highly …
Recursion's Drug Discovery Pipeline | Recursion
Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high …
Careers at Recursion: Join Our Mission | Recursion
Embark on a career journey with Recursion. Dive into opportunities, culture, and the impact you can make. Apply to work with us today!
Recursion's Story and Mindset | Recursion
Nov 5, 2013 · Embark on the captivating journey of Recursion. From humble beginnings to TechBio pioneers. Learn more about us and dive into our story now!
Meet our Team | Recursion
Get acquainted with the brilliant minds behind Recursion. Dive into our team's passion, expertise, and vision. Read more about our team today!
Our Unique Approach to AI Drug Discovery | Recursion
Unlike traditional drug discovery, which begins with a specific target or hypothesis, we leverage the Recursion OS — our drug discovery and development platform for AI in pharma connects …
Press Releases & Recursion News | Recursion
Sep 1, 2017 · Stay updated with the latest press releases and news from Recursion. Dive into our achievements, announcements, and more. Explore now!
Technology - Recursion
By leveraging Recursion’s vast data universe and machine learning models at every stage of the discovery, design and delivery process, we are able to rapidly validate and accelerate high …
Najat Khan, Ph.D. - Recursion
At Recursion, Dr. Khan has combined bold vision with disciplined leadership to advance value and impact.
Recursion Pharmaceuticals, Inc. - Press Releases
May 6, 2025 · Five of six patients (83%) experienced reductions in polyp burden ranging from 31% to 82%, however, one patient showed a substantial Apr 28, 2025 Recursion to Report …